Monitoring how T cells respond to HIV

October 14, 2011 by Anne Trafton in HIV & AIDS

Monitoring how T cells respond to HIV

Enlarge

Inside these squares, single T cells taken from HIV-infected patients interact with infected cells. This technology, developed by MIT chemical engineers, offers the first way to study how effectively individual T cells respond to HIV-infected cells. Image: Navin Varadarajan

One of the obstacles to developing an effective AIDS vaccine is the difficulty in measuring how well a potential vaccine primes the body to defend itself against HIV.

Ideally, scientists would like their vaccines to provoke T , a critical component of the , to recognize and kill HIV-infected cells. Unfortunately, there is no fast and easy way to monitor whether T cells are actually doing that. Instead, researchers measure the amount of a protein called interferon gamma that T cells secrete when they encounter an infected cell. Studies have shown, however, that this “surrogate” measurement doesn’t necessarily predict a T cell’s ability to kill HIV-infected cells.

In an advance that could overcome that obstacle, a team of researchers at MIT has developed a new technology that can measure multiple aspects of individual T cells’ responses to HIV-infected cells, including their ability to kill them. The technology could make it easier to monitor and design vaccines against , says J. Christopher Love, the Latham Family Career Development Associate Professor of Chemical Engineering and leader of the research team.

The technology, described in a paper published in the Oct. 3 online edition of the Journal of Clinical Investigation, involves two steps. First, the researchers place single T cells taken from HIV-infected patients into tiny wells on a plate, where they are exposed to HIV-infected cells. The researchers can detect whether the T cells kill the infected cells with probes that glow when the dying cells’ nuclei become compromised.

Watch T cells attack HIV-infected cells:

This video is not supported by your browser at this time.

Next, the researchers measure interferon gamma production with a microengraving technique they developed in 2008. Secretions from each cell are imprinted on a glass slide, which can then be tested for the presence of specific proteins. Because each cell has its own “address” on the slide, the secretions can be traced back to individual cells, and their interferon gamma production can be correlated directly to their cell-killing ability.

The same technology could be adapted to measure cells’ output of any other immune system .

In this study, the researchers found that while the percentage of that secrete interferon gamma is similar to the percentage of those that kill infected cells, the populations are not identical. In future studies, the researchers hope to find markers that do correlate with cell-killing ability, making it easier to evaluate a potential ’s effectiveness.

“Now that we have a tool to look directly at a variety of different functional activities, you can go in and start to evaluate other markers that may be better predictors of killing. Those then become what you would want to monitor in vaccine trials,” says Love, who is also a member of the Ragon Institute of MGH, MIT and Harvard and the David H. Koch Institute for Integrative Cancer Research at MIT.

“The appeal of this technology is that it can help us understand more about what’s going on in single cells,” says Alan Landay, professor of immunology and microbiology at Rush Medical College. “It helps us rethink what we understand about immunology and immune function.”

More research will be needed to develop the technology to the point where it can be used routinely in vaccine trials for large-scale studies of patient samples.


This story is republished courtesy of MIT News (web.mit.edu/newsoffice/), a popular site that covers news about MIT research, innovation and teaching.

Provided by Massachusetts Institute of Technology search and more info website

3 /5 (1 vote)  

Rank 3 /5 (1 vote)
Related Stories
Relevant PhysicsForums posts

More news stories

AIDS science at 30: 'Cure' now part of lexicon

Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.

HIV & AIDS created 2 hours ago | popularity not rated yet | comments 0

Peer-referral programs can increase HIV-testing in emergency departments

Researchers at the University of Cincinnati (UC) have found that incorporating a peer-referral program for HIV testing into emergency departments can reach new groups of high-risk patients and brings more patients into the ...

HIV & AIDS created 16 hours ago | popularity not rated yet | comments 0

HIV no barrier to getting liver transplant, study finds

(HealthDay)—Liver transplants to treat a common type of liver cancer are a viable option for people infected with HIV, according to new research.

HIV & AIDS created 16 hours ago | popularity not rated yet | comments 0

Twin epidemics: HIV and Hepatitis C in the urban Northeast

A new Yale study looks at the scope and consequences of a burgeoning health problem in the cities of the U.S. Northeast: concurrent infection with both HIV and Hepatitis C (HCV). The study appears online ...

HIV & AIDS created 20 hours ago | popularity not rated yet | comments 0

Russia has 'no anti-AIDS strategy', official says

There is no government strategy to fight the spread of AIDS in Russia, where the number of deaths caused by the disease continues to grow, a senior healthcare official said on Thursday.

HIV & AIDS created May 16, 2013 | popularity not rated yet | comments 0


For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests

Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or ...

Temporal processing in the olfactory system

The neural machinery underlying our olfactory sense continues to be an enigma for neuroscience. A recent review in Neuron seeks to expand traditional ideas about how neurons in the olfactory bulb might encode information about ...

Melon focus headband turns to Kickstarter for rollout plans

(Medical Xpress)—What if the quality of your work depends more on your focus on the piano keys or canvas or laptop than your musical or painting or computing skills? If target users can be convinced, they ...

Now we know why old scizophrenia medicine works on antibiotics-resistant bacteria

In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as ...

Study identifies new approach to improving treatment for MS and other conditions

(Medical Xpress)—Working with lab mice models of multiple sclerosis (MS), UC Davis scientists have detected a novel molecular target for the design of drugs that could be safer and more effective than current FDA-approved ...

College women exceed NIAAA drinking guidelines more frequently than college men

In order to avoid harms associated with alcohol consumption, in 2009 the National Institute on Alcohol Abuse and Alcoholism issued guidelines that define low-risk drinking. These guidelines differ for men and women: no more ...